XORTX Therapeutics Inc. filed a Form 6-K report on April 28, 2025, pertaining to their foreign private issuer activities. The filing is significant for investors as it updates on the company's compliance and operational status.
AI Assistant
XORTX THERAPEUTICS INC
2025
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.